12 December 1997
De Novo Cancers Complicating Renal Transplantation: Experience in The Nordic Countries
Sven Arvid BirkelandAnn Transplant 1997; 2(4): 22-26 :: ID: 497337
Abstract
Objectives. This report summarizes the experience in the Nordic countries with de novo cancer complicatingrenal transplantation and the prospects of a new Nordic EU-SPONSORED study (EURO-CA T) covering all kinds of organ transplantations. Methods. Epidemiological studies are performed using standard methods of cohort analysis. The expected numbers of cancer cases in each stratum are calculated by applying the stratum- and site-specific cancer incidence rate of the national population to the appropriate number of person-years at risk. The observed/expected ratio is taken as the relative risk (standardized incidence ratio, SIR). Differences in SiRs between subcohorts are tested by evaluating the rate ratio. Laboratory methods include immunopathological, virus serological, cytokine and tissue type analyses. Treatment includes discontinuation of immunosuppression and long-term high dose aciclovir. Results. In our most recent analyses an incidence 3 - 5 times higher than that of the general population has been found, including most types of tumors, however with an uneven pattern with emphasis on lip- cervical-, vulvar-, urological-, skin cancers and Iymphoprolipherative disorders (PTLD). Most tumors occur early (incl. PTLD) after transplantation, tumors of the skin however later and with an increase with time. In our present analysis we follow alltypes of organ transplantation, up to the most recent date, to consider the many new immunosuppressive agents for their risk of inducingcancer. Laboratoryanalyseshave pointed to IL-IOas a possiblecofactor in the development of EBV-inducedPTLD.Treatment with aciclovirand discontinuation of immunosuppression may in some cases lead to recovery from the malignancy, sometimes even without harming the graft function.
Keywords: cancer, Transplantation, Immunosuppression
In Press
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860